As September concludes, the landscape of hematologic oncology continues to evolve, spanning the full spectrum of blood cancer ...

Subcutaneous isatuximab plus bortezomib, lenalidomide, and dexamethasone is effective in transplant-ineligible, newly diagnosed multiple myeloma.

Discover Quince Therapeutics’ breakthrough drug-delivery platform aiming to safely treat rare diseases with encapsulated steroids.

Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response Rate (ORR) at the Highest Dose Level (100 µg) and a 40% ORR at the ...

Combining the oral drug ixazomib and lower-dose lenalidomide shows important reductions in neutropenia and peripheral ...

C4 Therapeutics' zinc finger protein-1 and 3 (IKZF1/3) degrader cemsidomide has demonstrated an overall response rate (ORR) ...

A growing list of contemporary phase 3 trials have shown that more drugs (quadruplet therapies) are superior to less drugs ...

"We are well aware that four-drug regimens with anti-CD38 monoclonal antibodies, lenalidomide, proteasome inhibitors, and ...

The drug, iberdomide, is one of a few protein-degrading medicines the company hopes to become successors to its blockbuster ...

Using steroids for longer than 6 months to treat vernal keratoconjunctivitis significantly increases the risk for steroid-induced glaucoma, even with lower-potency steroids, according to a study ...

More than half of adults who underwent a unilateral adrenalectomy to treat mild autonomous cortisol secretion developed adrenal insufficiency, according to data published in The Journal of Clinical ...

Cystatin C is an emerging biomarker that enhances kidney function assessment accuracy, particularly in hospitalized patients ...